First Survival Win for CDK4/6 Inhibitors in High-Risk Early-Breast Cancer

By News Health
2 months Ago

(MedPage Today) — BERLIN — For the first time in a phase III trial, adjuvant treatment with a CDK4/6 inhibitor significantly improved overall survival (OS) in high-risk early breast cancer, data reported here showed.
Patients who received…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118016

Author :

Publish date : 2025-10-18 17:26:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Cardiologist Heads New ACIP; Distal Access Catheter Recall; Another Lipid Marker?

Delaying Hep B Vaccine in Infants Carries Significant Risks, Report Warns

Join the Lifeline Chorus and Help Fight AMR

Is Your Patient Taking Herbs and Vitamins? You Won't Know Unless You Ask.

Black hole entropy hints at a surprising truth about our universe

Congo Declares Its Latest Ebola Outbreak Over, After 43 Deaths